Cargando…

The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis

Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for whom it fails. We hypothesize that the therapy-induced inflammatory responses inhibit the cancer progression, and thereby lead to a longer survival. Thirty-three consecutive patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Li-Han, Soong, Thomas C., Chu, Nei-Min, Huang, Chung-Yu, Kao, Shu-Huei, Lin, Yung-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763363/ https://www.ncbi.nlm.nih.gov/pubmed/33322487 http://dx.doi.org/10.3390/jcm9124010

Ejemplares similares

Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study
por: Hsu, Li-Han, et al.
Publicado: (2016)

Clinical outcomes of chemical pleurodesis using a minocycline
por: Hsu, Li-Han, et al.
Publicado: (2019)

Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
por: Ibrahim, Islam M, et al.
Publicado: (2015)

Efficacy and Safety of Povidone-iodine Pleurodesis in Malignant Pleural Effusions
por: Kahrom, Hadi, et al.
Publicado: (2017)

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion
por: Yokoe, Norihito, et al.
Publicado: (2017)

Adverse events after pleurodesis in patients with malignant pleural effusion
por: Terra, Ricardo Mingarini, et al.
Publicado: (2020)

Ambulatory Thoracoscopic Pleurodesis Combined With Indwelling Pleural Catheter in Malignant Pleural Effusion
por: Foo, Chuan T., et al.
Publicado: (2021)

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion
por: Masoud, Hossam Hosny, et al.
Publicado: (2021)

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin
por: Rafiei, Rahmatollah, et al.
Publicado: (2014)

Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis
por: Xia, Huan, et al.
Publicado: (2014)

Survival and pleurodesis outcome in patients with malignant pleural effusion – a systematic review
por: Hassan, Maged, et al.
Publicado: (2021)

Still’s disease with pleural effusion submitted to a pleurodesis
por: Carvalho, Jozélio, et al.
Publicado: (2021)

Multimodal approach to the management of malignant pleural effusions: role of thoracoscopy with pleurodesis and tunneled indwelling pleural catheters
por: Agrawal, Abhinav, et al.
Publicado: (2020)

A novel approach for preventing recurrence of malign pleural effusion: early phase pleurodesis
por: Cobanoglu, Ufuk, et al.
Publicado: (2018)

Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria
por: Omoregbee, Benjamin Irene, et al.
Publicado: (2021)

Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status
por: Terra, Ricardo Mingarini, et al.
Publicado: (2011)

Silver nitrate versus tetracycline in pleurodesis for malignant pleural effusions; a prospective randomized trial
por: Tabatabaei, Seyed Abass, et al.
Publicado: (2015)

Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial
por: Keeratichananont, Warangkana, et al.
Publicado: (2018)

Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion
por: Kim, Jeong Eun, et al.
Publicado: (2012)

Video-assisted thoracoscopic iodopovidone pleurodesis for malignant pleural effusions in moderate to high-risk Colombian patients
por: Garzón, Juan Carlos, et al.
Publicado: (2020)

Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non‐small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination
por: Liu, Baodong, et al.
Publicado: (2016)

Ultrasound-guided intrapleural positioning of pleural catheters: influence on immediate lung expansion and pleurodesis in patients with recurrent malignant pleural effusion
por: de Araujo, Pedro Henrique Xavier Nabuco, et al.
Publicado: (2017)

Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial
por: Psallidas, Ioannis, et al.
Publicado: (2017)

Predictors of survival in patients who underwent video‐assisted thoracic surgery talc pleurodesis for malignant pleural effusion
por: Yoon, Dong Woog, et al.
Publicado: (2016)

Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials
por: Wang, Li, et al.
Publicado: (2020)

Does attempting talc pleurodesis affect subsequent indwelling pleural catheter (IPC)-related non-draining septated pleural effusion and IPC-related spontaneous pleurodesis?
por: Asciak, Rachelle, et al.
Publicado: (2019)

Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis
por: Fysh, Edward T H, et al.
Publicado: (2014)

Release of growth factors after mechanical and chemical pleurodesis for treatment of malignant pleural effusion: a randomized control study
por: Hojski, Aljaz, et al.
Publicado: (2015)

Chemical pleurodesis using mistletoe extracts via spray catheter during medical thoracoscopy for management of malignant pleural effusion
por: Eom, Jung Seop, et al.
Publicado: (2017)

Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion
por: Fitzgerald, Deirdre B., et al.
Publicado: (2022)

Potential Role of Pleural Fluid Cytokine Profile in Myelomatous Pleural Effusions
por: Xu, Junhui, et al.
Publicado: (2021)

Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion
por: Martin, Geoffrey A, et al.
Publicado: (2018)

FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy
por: Genestreti, Giovenzio, et al.
Publicado: (2012)

Microbiome profile associated with malignant pleural effusion
por: Shojaee, Samira, et al.
Publicado: (2020)

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
por: Verma, Akash, et al.
Publicado: (2016)

Which is the More Effective Option for Pleurodesis to Prevent the Recurrence of Malignant Pleural Effusion? Large-Particle Talc or Mistletoe Extract (ABNOVA Viscum Injection)
por: Han, Changsung, et al.
Publicado: (2023)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tdf1c4i3gg36ck2df236fd1ecn